Dorsey Wright & Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Dorsey Wright & Associates’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,673	Closed	-$94K	–	350
2021 Q2	$94K	Hold	3,673	–	–	0.02%	135
2021 Q1	$67K	Buy	3,673 +2,109	+135%	+$35K	0.79%	26
2020 Q4	$18K	Buy	1,564 +391	+33%	+$3.58K	﹤0.01%	190
2020 Q3	$9K	Buy	+1,173	New	+$8.88K	﹤0.01%	218
2019 Q1	–	Sell	-2,642	Closed	-$11K	–	337
2018 Q4	$11K	Buy	2,642 +440	+20%	+$2.3K	﹤0.01%	262
2018 Q3	$15K	Buy	+2,202	New	+$13.1K	﹤0.01%	224

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dorsey Wright & Associates's CDMO Position: Q3 2021 in Review

Dorsey Wright & Associates sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2021, closing a stake of 3,673 shares — an estimated $94K sold.

Dorsey Wright & Associates first reported a position in CDMO in Q3 2018 and held it in 6 quarters. The position peaked at $94K in Q2 2021. 161 funds tracked by Wall St. Rank hold CDMO as of Q3 2021.

Dorsey Wright & Associates reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Dorsey Wright & Associates sold 3,673 Avid Bioservices, Inc. Common Stock shares in Q3 2021, an estimated $94K.
Dorsey Wright & Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
Dorsey Wright & Associates's Avid Bioservices, Inc. Common Stock position peaked at $94K in Q2 2021.
161 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2021.

Based on Dorsey Wright & Associates's 13F filing for Q3 2021, filed 26 Oct 2021.